Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
MG-132 in Ferroptosis Research: A Protein-Turnover Lens
2026-09-24
MG-132 (Z-LLL-al) can help researchers test how proteasomal protein turnover intersects with ferroptosis resistance. This article connects the OTUD3–SLC7A11 findings in clear cell renal cell carcinoma to practical assay design—and explains why proteasome inhibition alone cannot establish ferroptosis.
-
PR-619: Practical Guide to DUB Assays
2026-09-24
Use PR-619 as a reversible, broad-spectrum perturbation to investigate deubiquitylating enzymes and ubiquitin-dependent cell biology—not as a proteasome inhibitor or a stand-alone way to identify one DUB. This guide covers stock preparation, cell-based assay design, interpretation, and practical controls for cancer and neurodegeneration research.
-
Splicing and Stability Time TRIM46 During Axon Formation
2026-09-24
The study shows that TRIM46 protein appears during axon formation through coordinated changes in transcription, alternative splicing, mRNA decay, and protein stability. Its results position two independently regulated exons as a temporal and neural-specific control system, while indicating that TRIM46 is instructive for AnkG localization but not invariably required for it.
-
H 89 2HCl for PKA Signaling Workflows
2026-09-23
H 89 2HCl enables controlled interrogation of cAMP/PKA signaling, from phosphorylation assays to neurite-growth and neuroinflammation models. This guide translates its biochemical selectivity into practical workflows while showing how to separate PKA-dependent effects from concentration-dependent off-target activity.
-
Catalpol in Diabetes: Pharmacology, PK, and Safety
2026-09-22
The reference review integrates preclinical evidence that Catalpol, also known as Catalpinoside, may improve glucose regulation and protect against diabetic kidney, cardiovascular, nervous-system, and bone complications through multi-pathway control of inflammation, oxidative stress, apoptosis, and metabolism. Its discussion of pharmacokinetics and safety is particularly useful for interpreting animal dosing, blood–brain barrier penetration, oral administration potential, and the limitations that remain before clinical translation.
-
D-Lin-MC3-DMA: From Mechanism to Translation
2026-09-22
D-Lin-MC3-DMA is more than a familiar ionizable lipid: it is a framework for connecting pH-responsive chemistry, RNA payload biology, machine-learning-guided formulation, and translational decision-making. This article examines how to use MC3 rationally across hepatic gene silencing and mRNA delivery while respecting the limits of preclinical evidence.
-
PR-619: A Mechanistic Probe for DUB Biology
2026-09-21
PR-619 is a reversible deubiquitylating enzymes inhibitor for resolving how ubiquitin signaling, proteostasis, autophagy, and cell-state phenotypes interact. This article connects assay design for PR-619 with the progenitor T-cell analysis framework used in a landmark tumor-immunology study.
-
Chaperone-Mediated Autophagy in Muscle Aging
2026-09-21
The reference study identifies chaperone-mediated autophagy (CMA) as an active regulator of skeletal-muscle maintenance rather than a passive response to ageing. Using muscle-specific Lamp2a deficiency, proteomics, calcium assays and aged-mouse rescue experiments, the authors connect declining CMA to SERCA dysfunction, abnormal calcium handling and progressive myopathy.
-
2X Taq PCR Master Mix for C. elegans Studies
2026-09-20
Build faster C. elegans genotyping, cloning, and sequence-verification workflows with a ready-to-use Taq formulation and integrated gel-loading dye. The mix is especially useful for testing pheromone-signaling models because it supports endpoint PCR, direct gel loading, and TA cloning without adding a separate loading-buffer step.
-
Bifidobacterium, FMT, and PET in Chronic HE
2026-09-19
This 2025 European Journal of Neuroscience study compares Bifidobacterium and fecal microbiota transplantation in bile duct ligation rats with chronic hepatic encephalopathy. Its main innovation is the use of regional [18F]PBR146 micro-PET/CT imaging to detect treatment-associated neuroinflammatory differences that were not evident in global brain uptake, behavioral testing, or circulating cytokines.
-
MG-262: Reversible Proteasome Inhibition
2026-09-19
MG-262, also called Z-Leu-Leu-Leu-B(OH)2, is a cell-permeable, reversible inhibitor of proteasome chymotryptic activity. Its controlled use can support proteasome inhibition assay design, apoptosis research, cell cycle arrest studies, and mechanistic analysis of muscle proteostasis.
-
Grazoprevir Hydrate: From Protease Biology to Translation
2026-09-18
A translational framework for using Grazoprevir hydrate and MK-5172 hydrate to connect NS3/4A protease biology, genotype-aware assay design, resistance strategy, pharmacokinetics, and clinically relevant HCV research populations.
-
Bortezomib (PS-341): Proteasome Research Guide
2026-09-17
Bortezomib, also called PS-341, is a reversible 20S proteasome inhibitor used in apoptosis assays, proteostasis studies, and approved cancer treatment. Product-reported benchmarks include 0.1 µM activity in H460 cells and 3.5–5.6 nM activity in canine melanoma cell lines.
-
FGF19–TRIM21–ANXA2 Axis in NPC Angiogenesis
2026-09-17
The reference study identifies an FGF19–TRIM21–ANXA2 regulatory axis that links nasopharyngeal carcinoma progression to tumor angiogenesis. Its combination of clinical profiling, cellular assays, animal models, and ubiquitination analysis supports FGF19 as a candidate biomarker and clarifies how altered protein turnover may enhance the vascular tumor microenvironment.
-
Curcumol, Methionine Metabolism, and HSC Death
2026-09-16
A 2026 study identifies disruption of methionine metabolism as a mechanistic component of curcumol-induced, autophagy-dependent death in hepatic stellate cells. Its partial rescue by S-adenosylmethionine links methyl-donor metabolism to antifibrotic cell-state control while highlighting important limits for translation beyond the LX-2 model.